BMT Data Book Including Cellular Therapy

Name: BMT Data Book Including Cellular Therapy
Price: 11.99 USD
Availability: InStock
ISBN: 9781107617551

ISBN-10: 1107617553

ISBN-13: 9781107617551

Edition: 3rd 2013 (Revised)

Authors: Reinhold Munker, Gerhard C. Hildebrandt, Hillard M. Lazarus, Kerry Atkinson

List price: $90.99

This item qualifies for FREE shipping.

30 day, 100% satisfaction guarantee!

Buy new: $122.04

Marketplace

2 new & used from $11.99

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

This is an essential guide to the data, basic science, outcome studies and decision-making processes involved in blood and marrow stem cell transplantation. Organized according to disease types and procedures, it contains more than 100 tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between different types of chemotherapy, autologous vs. allogeneic transplantation, peripheral blood vs. bone marrow stem cells, and standard vs. experimental treatments. This new edition summarizes the research of the last four years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndrome and Hodgkin and…

Book details

List price: $90.99
Edition: 3rd
Copyright year: 2013
Publisher: Cambridge University Press
Publication date: 2/21/2013
Binding: Paperback
Pages: 555
Size: 6.14" wide x 9.21" long x 0.94" tall
Weight: 2.024
Language: English

Gerhard C. Hildebrandt, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA.



Preface



Basic Science



Hematopoietic cell transplantation: past, present and future




Basic science




Hematologic Malignancies



Therapeutic decision making in BMT/SCT for acute myeloid leukemia




Therapeutic decision making in BMT/SCT for acute lymphoblastic leukemia




Therapeutic decision making in BMT/SCT for chronic myeloid leukemia and other myeloproliferative syndromes




Therapeutic decision making in BMT/SCT for chronic lymphatic leukemia




Therapeutic decision making in BMT/SCT for myelodysplasia




Hematopoietic cell transplantation for non-Hodgkin lymphoma




Therapeutic decision making in BMT/SCT for Hodgkin lymphoma




Therapeutic decision making in hematopoietic stem cell transplantation for multiple myeloma




Therapeutic decision making in SCT for amyloidosis




Solid Tumors



Therapeutic decision making in BMT/SCT for nonseminomatous germ cell tumor of testis (NSGCT)




Therapeutic decision making in BMT/SCT for renal cell cancer




Therapeutic decision making in BMT/SCT for soft tissue sarcomas




Nonmalignant Disorders



Therapeutic decision making in BMT/SCT for severe aplastic anemia




Therapeutic decision making in BMT/SCT for congenital immunodeficiencies




Therapeutic decision making in BMT/SCT for hemoglobinopathies




Hematopoietic stem cell transplantation for inborn errors of metabolism and neurodegenerative disorders




Therapeutic decision making in BMT/SCT for autoimmune disorders




Cellular therapy




Practical Aspects and Procedures



Practical aspects and procedures, including conditioning protocols and haploidentical transplantation




Umbilical cord blood as alternative allogeneic graft source: clinical banking and transplant outcomes




Complications



Pathobiology of graft-versus-host disease




Diagnosis and treatment of graft-versus-host-disease




Management and prophylaxis of infections after BMT/SCT




Organ-related and miscellaneous complications




The BMT/SCT Pharmacopoeia



The BMT/SCT pharmacopoeia




HLA-Testing and Laboratory Medicine



HLA-testing and laboratory medicine



Appendix: guide to the internet and literature databases relevant for bone marrow and stem cell transplantation


Index